Salt Lake City, Utah — December 16, 2019 — Epitel today announced it has received an investment from Ideaship, a patent leveraged venture capital firm that provides patent development support for early stage startups. The investment will assist Epitel’s mission to develop an EEG system solution for pre-clinical epilepsy research.
“Ideaship is very excited to be working with Mark Lehmkuhle and the Epitel team. Their wireless seizure monitoring device technology is a cutting edge progression to predicting epileptic seizures,” said Robert Bell, Ideaship Venture Partner.
“As a small start-up we have a lot of forward thinking ideas but lack the resources to protect that knowledge,” remarked Mark Lehmkuhle, CEO/CTO of Epitel. Mark further commented, “Ideaship will give us a much needed boost to our IP portfolio.”
Epitel is a digital health startup based in Salt Lake City, Utah. They specialize in medical-grade seizure monitoring with their non-invasive wearable EEG technology.
For more information, please visit https://www.epitel.com.
Ideaship provides patent development capital for early stage ventures.
Ideaship is a collaboration between Global Technology Transfer Group (GTT Group) and Panasonic Intellectual Property Corporation of America. Ideaship combines the expertise and experience of GTT Group’s patent analysis, valuation, and monetization practices with Panasonic Intellectual Property Corporation of America’s leading patent department to achieve enterprise value premiums.
For more information, please visit https://www.ideashipfund.com.